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ORIGINAL ARTICLE
Airway irritation, inflammation, and toxicity in mice following inhalation
of metal oxide nanoparticles
Søren T. Larsen1, Petra Jackson1, Steen S. Poulsen2, Marcus Levin1, Keld A. Jensen1, Ha˚kan Wallin1,
Gunnar D. Nielsen1, and Ismo K. Koponen1
1Danish Centre for Nanosafety, National Research Centre for the Working Environment, Copenhagen, Denmark and 2Department of Biomedical
Research, The Panum Institute, University of Copenhagen, Copenhagen, Denmark
Abstract
Metal oxide nanoparticles are used in a broad range of industrial processes and workers may be
exposed to aerosols of the particles both during production and handling. Despite the
widespread use of these particles, relatively few studies have been performed to investigate the
toxicological effects in the airways following inhalation. In the present study, the acute (24 h)
and persistent (13 weeks) effects in the airways after a single exposure to metal oxide
nanoparticles were studied using a murine inhalation model. Mice were exposed 60min to
aerosols of either ZnO, TiO2, Al2O3 or CeO2 and the deposited doses in the upper and lower
respiratory tracts were calculated. Endpoints were acute airway irritation, pulmonary inflam-
mation based on analyses of bronchoalveolar lavage (BAL) cell composition, DNA damage
assessed by the comet assay and pulmonary toxicity assessed by protein level in BAL fluid and
histology. All studied particles reduced the tidal volume in a concentration-dependent manner
accompanied with an increase in the respiratory rate. In addition, ZnO and TiO2 induced nasal
irritation. BAL cell analyses revealed both neutrophilic and lymphocytic inflammation 24-h post-
exposure to all particles except TiO2. The ranking of potency regarding induction of acute lung
inflammation was Al2O3 ¼ TiO25CeO2 ZnO. Exposure to CeO2 gave rise to a more persistent
inflammation; both neutrophilic and lymphocytic inflammation was seen 13 weeks after
exposure. As the only particles, ZnO caused a significant toxic effect in the airways while TiO2
gave rise to DNA-strand break as shown by the comet assay.
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Introduction
Metal oxide nanoparticles are important industrial materials and
they are used in a broad range of processes and products including
paint, catalysts, fuel additives, solar panels, glass polish, sun-
screens, cosmetics, and pharmaceutical products. During produc-
tion of the particles and the later handling by down-stream users,
the dry powder can form airborne dust which may be inhaled. Other
scenarios for metal oxide particle exposures include aluminum
smelting and welding galvanized steel, which liberates Al2O3 and
ZnO particles, respectively (Healy et al., 2001; ICRP, 1994).
Various acute health effects after exposure to metal oxides
have been observed. Among the best known effect is metal fume
fever caused by exposure to ZnO particles. This condition is most
commonly seen among welders few hours after welding
galvanized steel. Symptoms include chest pain, difficulties in
breathing, and flu-like symptoms (Antonini et al., 2003). Apart
from zinc, oxides of cadmium, copper, magnesium, and tin may
also induce metal fume fever (Antonini et al., 2003). Nickel oxide
and chromium oxide, both formed during welding stainless steel,
are recognized as lung carcinogens (IARC, 1990) whereas
inhalation of copper oxide, magnesium oxide, and barium oxide
may give rise to respiratory tract irritation (Antonini et al., 2003).
Pulmonary toxicity of metal oxide nanoparticles has been
investigated in animals. Endpoints studied include inflammation,
histopathological changes, oxidative stress, and in a few cases also
airway irritation. Animals have in most cases been exposed to the
material via intratracheal instillation of the material in an aqueous
suspension. The vehicle and dispersion protocols vary consider-
ably, making comparison across instillation studies complicated.
Furthermore, by bolus instillation, the entire dose is deposited in the
lungs within a few seconds, giving rise to an extremely high-dose
rate, which may drive a toxic response not seen if the same dose was
administered over a longer period (Driscoll et al., 2000). Apart from
TiO2, surprisingly few studies of metal oxide toxicity use inhalation
of a dry aerosol, although only inhalation reflects real-life exposure.
In inhalation studies, the exposure is often characterized by a
mass concentration (e.g. mg/m3) and a particle size distribution.
Very few studies estimate the deposited dose in the lungs after
airway exposure to a dry aerosol, although this knowledge is
crucial in order to compare results from inhalation studies with
data from instillation studies.
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In the present study, we exposed mice to one of five different
metal oxide nanoparticles by inhalation of a dry aerosol.
Investigated effects included acute and subchronic airway
inflammation. Furthermore, the pulmonary toxicities of ZnO,
TiO2, Al2O3, and CeO2 were assessed based on protein content in
bronchoalveolar lavage fluid (BALF) and histological analyses of
lung tissue. The levels of DNA-strand breaks, an indicator of
genotoxicity, were assessed by the comet assay. Finally, the
airway irritation potentials of the inhaled particles were studied,
since this provides information related to the ‘‘warning response’’
of the particle. Thus, a particle with low airway irritation potential
may be inhaled without feeling any discomfort and workers may
therefore be unaware of the exposure.
Methods
Animals
Inbred female BALB/cJ mice aged 6–7 weeks were purchased
from Taconic M&B, Ry, Denmark, and were housed in polypro-
pylene cages (380 220 150 mm) with pinewood sawdust
bedding (Lignocel S8, Brogaarden, Denmark). The cages were
furnished with bedding materials, gnaw sticks, and cardboard
tubes. The photo-period was from 6 a.m. to 6 p.m., and the
temperature and mean relative humidity in the animal room were
19–22 C and 43 ± 8% (SD), respectively. Food (Altromin no.
1324, Altromin, Lage, Germany) and tap water were available ad
libitum. Treatment of the animals followed procedures approved
by The Animal Experiment Inspectorate, Denmark (2011/561-
1990). At the time of exposure, the mice had a body weight of
21.1 ± 2.2 g (mean ± SD).
Chemicals
The following metal oxide nanoparticles were included in the
study: two types of ZnO (in the following referred to as ZnO_1
and ZnO_2), TiO2, Al2O3, and CeO2.
The ZnO_2 and CeO2 were from Evonik Degussa, GmbH
whereas the ZnO_1, TiO2 and Al2O3 were synthesized by
PlasmaChem (Berlin, Germany). The crystal phase of TiO2 was
anatase. Other data from the characterization of the particles are
given in Table 1. The size and size distribution of the
nanoparticles were determined using transmission electron
microscopy (TEM), the surface elemental composition was
determined by X-ray photoelectron spectroscopy (XPS) and the
specific surface areas of the bulk nanoparticles were determined
by means of the Brunauer–Emmett–Teller (BET) nitrogen
adsorption method as described (Levin et al., 2015).
Generation of test atmospheres and aerosol
characterization
All nanoparticles were aerosolized using a dry powder aerosol
generator (Microdosing system, Fraunhofer ITEM, Hannover,
Germany). The generator was operated at a pressure of 1.0 bar
which generated an airflow of 14.7 L/min. Particle number size
distribution spectra of ZnO_1, ZnO_2, TiO2, Al2O3, and CeO2
were characterized using an Electrical Low Pressure Impactor
(ELPI+, Dekati Ltd., Kangasala, Finland) which measures the
aerodynamic equivalent diameter in 14 channels ranging from
6 nm to 10mm. The number of distributions was converted to
particle mass distributions through assumption of spherical
particle shape and unit density. As seen in Table S1 in the
Supplementary material, standard deviations of the particle
numbers were in general less than 10% during the 1-h exposure.
We have used the Fraunhofer microdosing disk method previ-
ously and have good experience of it being a stable source for
particle delivery. By measuring on-line with ELPI and compar-
ing that data with mass sampled with filter we can verify that
our sampled mass concentrations are reliable. Calculations of
deposited doses were in all cases based on gravimetrical
sampling of particles. Aerosols were continuously collected
from the breathing zone of the mice throughout all exposure
studied and total aerosol mass concentrations were determined
gravimetrically by a filter sampling protocol (Clausen et al.,
2003). At higher concentrations, sampling was performed using
2 or 3 filters with a difference in time-weighed mass deposition
of less than 25%. The particle size distribution is only to a very
little degree affected by the total output of the aerosol generator
(cf. Figures in Supplementary material).
Total aerosol mass concentrations in the exposure chamber
ranged from 4 to 271 mg/m3 (Table 3). The exposure concentra-
tions were selected based on the toxicological and airway
irritation potency of the particles, observed in a pilot scale
range finding study. Due to the low inflammogenic and toxic
potency of TiO2, this compound was only studied at the highest
generable concentration, 271 mg/m3.
Mouse bioassay
The Notocord Hem (Notocord Systems SA, Croissy-sur-Seine,
France) data acquisition software was used to collect and
analyze respiratory parameters. Mice were placed in body
plethysmographs, which were connected to the exposure cham-
ber, and animals were exposed head-only (Vijayaraghavan et al.,
1994). The acquisition program calculates i.a. the respiratory
rate (f, [breaths per minute]), time from end of inspiration until
beginning of the expiration, termed time of break (TB, [s]), tidal
volume (VT, [mL]), mid-expiratory flow rate (VD, [mL/s]), and
the time of inspiration (TI, [s]). The inspiratory flow rate [mL/s]
was calculated as VT/TI. Comprehensive descriptions of the
breathing parameters have been made elsewhere (Larsen &
Nielsen, 2000; Vijayaraghavan et al., 1994). Data acquisition and
calculations were performed as described previously (Larsen
et al., 2004).
Following a 5- to 10-min acclimatization period, the mice
(n¼ 8–10 per group) were exposed 15 min to laboratory air, in
order to obtain control values for each breathing parameter for
Table 1. Characteristics of the studied metal oxide nanoparticles.
Compound
Primary size1 (nm)
Mean ± SD Characteristicsa
Specific surface
areab (m2/g)
Densityb
(g/cm3) Surface elemental compositionb Producer
ZnO_1 13.2 ± 5.4 Monodisperse, aggregated 26.2 5.6 16.9% C, 50.9% O, 32.2% Zn PlasmaChem
ZnO_2 36.1 ± 18.1 Polydisperse 21.9 5.6 20.7% C, 43.8% O, 35.5% Zn Degussa-Quimidroga
TiO2 10.0 ± 3.6 Aggregated 173.1 4.2 21.5% C, 42.2% O, 36.3% Ti PlasmaChem
Al2O3 13.6 ± 8.4 Polydisperse 76.3 4.0 5.5% C, 46.1% O, 48.4% Al PlasmaChem, Berlin
CeO2 13.0 ± 12.1 Polydisperse 56.7 7.2 22.1% C, 60.8% O, 17.0% Ce Evonik-Degussa
aData from Pe´rez-Campan˜a et al. (2012, 2013).
bData from Levin et al. (2015)
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each mouse. The baseline period was followed by a 60-min
exposure period, to allow the study of time-dependent respiratory
changes. After end of exposure, the mice were exposed to clean
laboratory air for 15 min, termed the recovery period.
Airway irritants may exert their action at different locations
of the respiratory tract depending on the pharmacological
nature of the compound and the deposition site, which is
dependent on physicochemical properties of the compound as
well as its the particle size. Based on the respiratory
parameters, it is possible to categorize the irritation as sensory
irritation, airflow limitation, or pulmonary irritation. Sensory
irritation is caused by a direct stimulation of the trigeminal
nerve endings in the upper respiratory tract (URT, Alarie, 1973;
Nielsen, 1991). This effect decreases the respiratory rate due to
an elongation of the TB, which is a specific marker of sensory
irritation.
Stimulation of vagal nerve endings at the alveolar level results
in characteristic modifications of the breathing pattern. One type
of reflex reaction may be rapid, shallow breathing (RSB), which
is characterized by a decrease in VT and an increased respiratory
rate.
Estimating the deposited doses
To estimate the inhalable fraction (IF) of the exposed particle
concentrations, we used the method presented by Asgharian and
coworkers (2003, 2014) and Menache et al. (1995). In this way,
IFs were calculated using a semi-empirical equation developed for
rats and parametrized for mice by Asgharian et al. (2014).
IF ¼ 1 1
1þ ðd2aeQÞ
where coefficients for mice are a¼ 9.92 and b¼0.7466,  is
particle density, dae is aerodynamic diameter, and Q is inspiratory
flow rate (cf. Table 2). For all particles, a density of 1 g/cm3 was
applied.
To calculate the deposition efficiency in the URT the method
described by Asgharian et al. (2014) was used. The URT starts
from the nasal openings and extended through the nasal passages,
pharynx and larynx until the beginning of the trachea (Asgharian
et al., 2014). URT deposition was calculated for inertial depos-
ition and deposition by diffusion. URT deposition for estimating
inertial impaction (ZH-imp) was calculated using the method first
presented by Zhang & Yu (2015)
Himp ¼
ðd2aeQÞ
105 þ ðd2aeQÞ
 
where coefficients for the mice are a¼ 3.96 and b¼ 0.117
(Asgharian et al., 2014).
Deposition efficiency by diffusion (ZH-diff) was calculated
using
Hdiff ¼ 1 eD
Q
where D is the diffusion coefficient [cm2/s], a¼ 13.688 (inhal-
ation), b¼ 0.517, and g¼0.234 (Asgharian et al., 2014),
coefficients a, b, and g were derived by Cheng et al. (1990).
Following the method presented by Asgharian et al. (2014),
the inhaled fraction was calculated for the lower respiratory tract
(LRT). The LRT includes the conducting airways (tracheo-
bronchial (TB) region) and the pulmonary region (PUL)
(cf. Table 3). The TB comprises the trachea, bronchi, and
bronchioles whereas PUL is the alveolar ducts and sacs. Taken
together, the LRT comprises 22 airway generations (Asgharian
et al., 2014).
Table 3. Exposure concentrations and estimated deposited doses.
Estimated deposited dose (mg)
LRT
Material Total concentration (mg/m3) Inhaled volume over 60 min (L) PUL TB URT Total deposited in airways
ZnO_1 6 2.594 0.04 0.14 2.12 2.30
58 2.024 0.41 1.37 20.6 22.3
203 1.296 1.45 4.79 72.1 78.1
ZnO_2 4 3.489 0.02 0.09 1.28 1.31
26 3.236 0.14 0.55 8.29 8.49
53 2.874 0.19 0.64 16.9 17.0
TiO2 271 2.021 0.60 1.50 88.7 90.5
Al2O3 23 2.275 0.13 0.41 8.00 8.82
94 2.423 0.55 1.69 32.7 36.0
235 2.709 1.21 3.81 80.2 86.6
CeO2 8 2.683 0.06 0.17 2.77 3.13
30 2.672 0.21 0.65 10.4 11.8
152 2.598 0.76 2.38 51.3 54.3
The upper respiratory tract (URT) starts at the nasal openings and ends at the beginning of the trachea. The lower respiratory tract (LRT) includes 22
airway generations and can be divided into the tracheo-bronchial (TB, trachea, bronchi, and bronchioles) region and the pulmonary (PUL, alveolar
ducts, and sacs) region.
Table 2. Respiratory parameters.
Material
Total
concentration
(mg/m3)
Breathing
frequency
(min1)
0–60 min
Tidal
volume (mL)
0–60 min
Inspiratory
flow rate (mL/s)
0–60 min
Control 0 254 ± 7 193 ± 18 1.69
ZnO_1 6 234 ± 21 184 ± 22 1.63
58 210 ± 16 162 ± 20 1.42
203 185 ± 10 116 ± 16 1.03
ZnO_2 4 257 ± 10 226 ± 19 2.07
26 244 ± 20 221 ± 10 2.13
53 224 ± 21 214 ± 24 1.89
TiO2 271 198 ± 9 170 ± 22 1.49
Al2O3 23 256 ± 6 148 ± 23 1.35
94 295 ± 14 137 ± 16 1.26
235 330 ± 15 137 ± 14 1.25
CeO2 8 248 ± 17 180 ± 17 1.62
30 277 ± 19 160 ± 15 1.42
152 314 ± 17 138 ± 13 1.24
Values are mean ± SD.
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Deposition fractions were calculated applying the ICRP model
(Hinds, 1999; ICRP, 1994). Total deposition fraction (DFtot) is
the sum of URT, TB, and PUL deposition fractions (cf. Figure 1).
The deposited dose was calculated using the following
equation:
Deposited dose ¼ f  VT t c df,
where f¼ respiratory frequency [breath/minute], VT¼ tidal
volume [mL/breath], t¼ exposure time [minutes], c¼ concentra-
tion of particle in the size fraction [ng/mL¼mg/m3], df¼
deposited fraction.
The LRT-deposited dose was applied for assessing the
inflammatory and toxic properties of the particles. Since the air-
way irritation response of the particles is driven by the
concentration (deposited dose pr. time unit) rather than total
deposited dose, we also apply the unit ‘‘deposited dose per hour’’
in these cases (Figure 2b and c). Furthermore, as another
important aim of this study was to calculate from total air
concentration to actual deposited doses in different regions of the
airways, we also present the total air concentration (mg/m3), e.g.
Table 3.
Bronchoalveolar lavage procedure
The study of BAL cell composition was used to assess lung
inflammation. BAL cells were recovered by flushing the lungs
four times with 0.8 mL of physiological saline using a tracheal
cannula. The BAL fluids recovered were pooled and centrifuged
(500 g, 10 min, 4 C). The supernatant was stored for later
analyses and the pellet was re-suspended in a 100mL PBS
buffer containing heparin (20 IE/mL) and serum albumin
(0.003%). The total numbers of cells were determined using a
hemocytometer. For differential counts, cytospin preparations
were made (Cytospin2, StatSpin Inc., Norwood, MA) (1000 g,
4 min, RT). Slides were stained with May-Gru¨nwald/Giemsa and
all slides were inspected in a blinded manner by the same
technician. Cells were identified by standard morphology and
differentiated into neutrophils, eosinophils, epithelial cells,
lymphocytes, and macrophages. For each slide, 200 cells were
counted.
Assessment of genotoxicity
DNA-strand break levels were analyzed by the comet assay
described previously by Jackson et al. (2013). The strand breaks
measured by the assay present a mixture of different strand
breaks, alkaline labile sites, and transient breaks in the DNA due
to repair process (Collins, 2009). DNA-strand breaks were
determined on frozen BAL cell suspensions and lung tissue.
Organ samples were snap frozen in cryotubes (NUNC, Roskilde,
Denmark) directly after dissection and kept at 80 C until
analysis. Sample preparation and analysis was previously
described in detail (Jackson et al., 2013). BAL cells preserved
Figure 2. Effects of metal oxide nanoparticle exposures on selected breathing parameters. The tidal volume (VT) values are expressed as minimum
average values of 8–10 mice during the 60-min exposure period (a) or as time-response relationship for Al2O3 nanoparticles (b) or ZnO_1 (c). Figure 2d
shows the degree of nose irritation quantified by the time of break (TB) elongation.
Figure 1. Regional deposition fractions in mice lung of inhaled particles
via nasal breathing. Upper respiratory tract (URT): from nasal openings
to the beginning of the trachea. Tracheo-bronchial region (TB): trachea,
bronchi and bronchioles. Pulmonary region (PUL): alveolar ducts and
sacs. DFtot¼URT + TB + PUL.
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in dimethyl sulfoxide were thawed quickly at 37 C, while frozen
tissues were homogenized in Merchant’s medium. Cells were
suspended in agarose at 37 C, with final agarose concentration of
0.7%. Cells were embedded on Trevigen CometSlidesTM (30mL
per well for 20 well slide). Cooled slides were placed in lysis
buffer overnight at 4 C. Next day, slides were rinsed in
electrophoresis buffer, alkaline treated for 40 min.
Electrophoresis was run with 5% circulation (70 mL/min) for 20
or 30 min (BAL and lung, respectively) at applied voltage 1.15 V/
cm (38 V measured for whole electrophoresis chamber) and
measured current 300 mA. Slides were neutralized twice for
5 min, fixed in ethanol for 5 min and on warm plate at 45 C for
15 min. Cells were stained in 20 mL/slide bath with TE buffered
SYBRGreen fluorescent stain for 15 min, dried at 37 C for
10 min, UV-filter and cover slip were applied and DNA damage
was analyzed by IMSTAR PathfinderTM system. Related samples
were placed in same electrophoresis. The results are presented as
average % DNA in tail and tail length value for all cells scored on
each Trevigen CometSlidesTM well (average cells counted ± SD;
BAL: 885 ± 375, lung: 1322 ± 611). The day-to-day variation and
electrophoresis efficiency was validated by including on each
slide A549 epithelial lung cells exposed to PBS or 60 mM H2O2,
used as our negative and positive historical controls for the
electrophoresis (Jackson et al., 2013). The day-to-day variation
including all slides (n¼ 16, 8 for each electrophoresis) from this
experiment was 24 and 18%, BAL and lung, respectively.
Protein in BAL fluid
Total protein in BALF was determined using the BCA Protein
Assay Kit from Pierce, Rockford, IL according to the manufac-
turer’s instructions.
Histology
After collection of BALF, the lungs were fixed in situ. The chests
of the mice were opened and a polyethylene tube introduced into
the trachea. The polyethylene tube was connected to a syringe
containing 4% buffered paraformaldehyde, and the lungs were
inflated with the fixative to normal size. After 5 min, the lungs
were removed in toto and further fixated in formalin for at least
24 h. Tissues were embedded in paraffin in a standardized way
(horizontal cut through the hilum regions) and subsequently 7mm
thick slices were cut and stained with periodic acid-Schiff (PAS)
hematoxylin and examined for inflammation and morphological
changes by conventional bright field microscopy.
Statistics
The following test procedure was applied in order to reduce the
number of pair-wise comparisons: First, the numbers of inflam-
matory cells in BAL fluid in the exposure groups were compared
to the air control group by the Kruskall–Wallis non-parametric
ANOVA test. Only if a statistically significant effect was
apparent, the individual exposure groups were further compared
to the air group by Mann–Whitney’s U test. A p value of 0.05 or
less was considered statistically significant. The same procedure
was applied for the protein concentration in BAL fluid and the
data from the comet assay. Calculations were performed using the
Minitab Statistical Software, Release 14 Xtra (Minitab Inc., State
College, PA).
Results
Generation and characterization of aerosols
Measurements of all materials were showing similar number
distributions, number size distribution spectra were peaking from
295 (Al2O3) nm to 504 nm TiO2 and modal number concentra-
tions from 1.3e4 cm3 (ZnO_2) to 2.4e6 cm3 (Al2O3). Detailed
information on the particle sizes and concentrations is presented
in the Supplementary material. Particle size distributions were
largely independent on the particle concentration. The calculated
mass size distribution spectra were peaking in around 1mm.
Table 1 presents a primary size of these materials and it is
apparent that particles in the aerosol are aggregates or agglom-
erates of primary particles.
Particle deposition in the airways
Based on particle size distribution of the aerosol, the particle
concentration, minute ventilation, and inspiratory flow rate (cf.
Method section), estimates of the deposited doses were calculated
(Tables 2 and 3). Total deposited doses (URT + LRT) ranged from
1.31 to 90.5 mg per animal during the 60-min exposure period. In
all cases, the major part of the dose was deposited in the URT,
whereas 0.11–6.24 mg reached the LRT. Only minor doses (0.02–
1.45 mg) reached the PUL.
Airway irritation
All particles studied induced a time- and concentration-dependent
reduction in the tidal volume (Figure 2a–c). No major difference
was seen in maximum suppression of the tidal volume among the
particles (Figure 2a). However, the kinetics of the responses were
different; for TiO2, Al2O3, and CeO2 and the response was
characterized by a rapid onset of effect reaching full response
after a few minutes of exposure, followed by a plateau throughout
the exposure period. After cessation of exposure, the response
partly returned to baseline level. As an example, the response to
Al2O3 is shown in Figure 2(b). For Al2O3 and CeO2, the reduction
in tidal volume was accompanied by an increase in respiratory
frequency (Table 2). The two types of ZnO particles gave rise to
another type of response; for these particles, a gradual reduction
in tidal volume was observed during the whole 60-min exposure
period. During the 15-min post-exposure period, no recovery of
the mice was observed. As an example, the response for ZnO_1 is
shown in Figure 2(c). Follow-up measurement 6- and 24 h after
exposure showed little normalization of the breathing (data not
shown). For all studied particles, the decrease in tidal volume was
accompanied by a reduction in the expiratory flow rate (data not
shown).
Another type of airway effects, sensory (nose) irritation, was
observed after exposure to TiO2 and both types of ZnO. Sensory
irritation response can be identified and quantified from the
elongation of the TB (Figure 2d). Neither Al2O3 nor CeO2
induced any nose irritation even at the highest exposure concen-
trations (Figure 2d). The elongated TB in the TiO2 and the two
ZnO groups reduced the breathing frequency in these animals
(Table 2).
Lung inflammation
Exposure to ZnO_1 as well as ZnO_2 gave rise to an increased
number of both neutrophils (Figure 3a) and lymphocytes
(Figure 3b) in the BAL fluid 24-h post-exposure. In contrast,
neither TiO2 nor Al2O3 exposure gave rise to any significant
increase in the number of inflammatory cells even at the highest
doses deposited in the LRT (2.1 and 5.0 mg, respectively).
The potency of the particles to induce acute neutrophilic lung
inflammation was: Al2O3 ¼ TiO25CeO25ZnO_15ZnO_2.
Based on lymphocytic inflammation, the ranking was
Al2O3¼TiO2¼CeO25ZnO_15ZnO_2.
In general, the studied particles had little effect on the number
of alveolar macrophages in BAL fluid (Figure 3c). However,
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exposure to ZnO_1 caused a reduction in the macrophage number
(p50.05). The other ZnO particle studied, ZnO_2, did not induce
a similar effect.
13 weeks after exposure, increased levels of both neutrophils
and lymphocytes were only seen in mice exposed to CeO2 (data
not shown).
Genotoxicity
One-hour exposure to TiO2 resulting in a LRT deposition of
2.1mg increased levels of DNA-strand breaks in the lung tissue
detectable 24 h after exposure. DNA-strand breaks shown by the
comet assay were apparent both from tail length and % DNA in
the tail (Table 4). The other investigated particles did not increase
DNA-strand breaks significantly.
Lung toxicity
Toxic effect of inhaled particles was seen for both types of ZnO,
where increased levels of total protein were seen in BALF 24-h
post-exposure (Table 4). The ZnO_2 appears to be more toxic
than the ZnO_1 since 26 mg/m3 ZnO_2 (0.69 mg deposited in
LRT) gave rise to a protein level in BAL equivalent to 58 and
203 mg/m3 ZnO_1 (corresponding to 1.78 and 6.24 mg deposited
in LRT).
No increased protein levels in BALF were observed 13 weeks
after exposure (data not shown).
The toxic effect of 53 mg/m3 ZnO_2 (0.83mg deposited in
LRT) on the lung tissue was further confirmed by histology.
Desquamation of bronchiolar cells (Figure 4b) and vacuolization
and necrosis of Clara cells (Figure 4c) was seen in the mice 24 h
after ZnO_2 exposure. No histological change was seen 13-week
post-exposure in any of the exposure groups.
Discussion
In the present study, we investigated the inflammogenic and toxic
properties of a range of metal oxide nanoparticles. Of the studied
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Figure 3. Neutrophils (a), lymphocytes (b) and macrophages (c) in BAL fluid from mice 24 h after exposure to metal oxide nanoparticle giving rise to
lower respiratory depositions of 0.11–6.2 mg. Mean ± SEM of groups of 8–10 mice are presented.
Table 4. Toxicological effects of metal oxide nanoparticle exposure.
Comet assay
Material
Particle
concentration
(mg/m3)
Protein in
BAL fluid
(mg/mL) Tail length % DNA in tail
Control 0 146 ± 51 21.2 ± 2.6 6.0 ± 0.8
ZnO_1 6 94 ± 22 – –
58 399 ± 70*** 27.5 ± 4.6 9.9 ± 2.5
203 371 ± 195** – –
ZnO_2 4 204 ± 102 33.3 ± 8 10.6 ± 3.3
26 422 ± 179*** 27.3 ± 6.4 8.8 ± 1.7
53 655 ± 285*** 23.7 ± 2.9 14.2 ± 13.1
TiO2 271 234 ± 145 39.0 ± 9.5* 20 ± 8.6*
Al2O3 23 – 22.6 ± 1.9 7.4 ± 1.6
94 303 ± 134 23.4 ± 4.9 8.0 ± 2.7
235 213 ± 51 32.2 ± 7.4 11.4 ± 4.8
CeO2 8 116 ± 86 36.5 ± 9.2 19.3 ± 8.5
30 107 ± 71 23.1 ± 5.8 7.2 ± 2.5
152 149 ± 65 28.4 ± 9.5 11.7 ± 6.7
Values are mean ± SD. Statistically significant increases compared to the
negative control group are indicated by *p 0.05, **p 0.01, or
***p 0.001.
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particles, the two types of ZnO were by far the most
inflammogenic. ZnO was also the most toxic substance assessed
by protein content in BALF and by histological analyses.
Inflammation as well as toxic effect occurred after 1-h exposure
to 26 mg/m3 ZnO_2 and 58 mg/m3 ZnO_1 corresponding to LRT
deposited doses of 0.69 and 1.78 mg per mouse, respectively
(approx. 30 and 80 mg/kg, respectively) (cf. Table 3). This
observation is in line with another inhalation study, where rats
were exposed 6 h to ZnO nanoparticles with a diameter of 35 or
250 nm, respectively. Lung inflammation and increased BALF
protein was seen at concentrations of 12.1 and 45.2 mg/m3, for the
35 nm and 250 nm particle sizes, respectively (Ho et al., 2011).
Chen et al. (2015) exposed mice to 0.86 mg/m3 ZnO nanoparticles
for 5 h. The primary particle size was about 9 nm whereas the
particle aggregates/agglomerates in the aerosol was about 67 nm
in average. Acute lung inflammation, mainly located at the
bronchoalveolar junctions, was seen 24-h post-exposure.
Inflammatory effect of ZnO has also been demonstrated in
rodents after intratracheal instillation, although at much higher
doses. Thus Sayes et al. (2007) instilled 1 or 5 mg/kg of ZnO
nanoparticles or fine ZnO particles intratracheally in rats. Twenty-
four hours after exposure, lung inflammation, based on total cell
number in BALF, was absent at the 1 mg/kg level, whereas
5 mg/kg nanosized (but not microsized) particles induced inflam-
mation. This is in line with observations recently reported by
Jacobsen et al. (2015), where both neutrophilic as well as
lymphocytic inflammation was absent 1 day after instillation
or aspiration of 18mg ZnO/mouse, corresponding to approx.
1 mg/kg. In the study by Jacobsen et al. (2015), no increased
protein level in BALF was observed 24 h after instillation of doses
up to 18 mg/mouse. In the present inhalation study, statistically
significant increased levels of lavageable protein were seen after
LRT deposition of only 0.7 mg ZnO per mouse. This suggests that
inhalation studies may be more sensitive than instillation studies
to reveal adverse effects of particles.
The low inflammatory potency of TiO2 seen in the present
study is supported by previous studies where TiO2 particles were
administered by inhalation (Leppanen et al., 2015) or instillation
(Warheit et al., 2006, 2007). Cho et al. investigated the
inflammatory effects of several metal oxide nanoparticles (Cho
et al., 2012). Rats were i.t. instilled with two different doses of
particles and endpoints were evaluated 24-h and 4-week post-
exposure, respectively. Based on BAL fluid cells, CeO2 and ZnO
were both able to induce inflammation 24 h after instillation,
whereas no inflammatory effects were seen by TiO2, which is
fully in accordance with our observations. Cho et al. (2012)
showed that 4 weeks after instillation of CeO2, increased levels of
neutrophils were seen, which is also in agreement with observa-
tions in the present study.
The DNA-damaging effect of TiO2 observed in the present
study is in line with other studies exposing different cell types to
nanosized TiO2 (Gopalan et al., 2009; Karlsson et al., 2008;
Ciliated cell
Clara cell
Desquamated bronchiolar cells
Only smooth muscle
cells remains
same
(a) (b)
(c)
Figure 4. Lung from mouse 24 h after exposure to air (a) or ZnO_2 (b and c). ZnO exposure lead to desquamation of bronchiolar cells as shown in
panel b, and vacuolization and necrosis of Clara cells (c). The deposited dose of Zn_2 in the lower respiratory tract is 0.83mg. The slide section is
representative for effects seen in the group.
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Wang et al., 2007). In a study comparing the DNA-damaging
potency of a range of different metal oxide nanoparticles,
including CuO, TiO2, ZnO, and iron oxides, TiO2 was found to
be more potent than ZnO (Karlsson et al., 2008). This result is
also confirmed in the present study.
The airway irritation potential of metal oxide nanoparticles has
only been assessed for a limited number of substances. Recently,
TiO2 was studied (Leppanen et al., 2011, 2015). It was found that
TiO2 nanoparticles with a primary particle size of approx. 20 nm
and a peak in aggregate size of about 100 nm gave rise to airway
effects at a concentration of 8 mg/m3. The main effect was a
reduced expiratory flow rate and a minor sensory irritation.
Exposure to larger, pigment grade TiO2 particles induced only
minor respiratory effects, suggesting that particle size may play a
role for sensory irritation response. In the present study, both ZnO
and TiO2 induced sensory irritation, the first being the more
potent. The TiO2 particle we used was stabilized with nitric acid,
and a part of the sensory irritation response may therefore be due
to residues of acid, which is a strong airway irritant. The airway
irritation of ZnO may be driven by a direct stimulation of the
transient receptor ankyrin (TRP) A1 receptor since previous study
has shown that the Zn2+ ion is a specific agonist for this receptor
(Hu et al., 2009).
Whereas the sensory irritation response is most likely due to
activation of specific receptors, all studied particles, irrespective
of chemical composition, reduced the tidal volume in a concen-
tration-dependent manner. No difference in potency was seen
across the particles, suggesting that the onset of this type of
airway response may be due to a nonspecific physical reaction.
However, whereas the effects rapidly resolved after cessation of
exposure for TiO2, Al2O3, and CeO2 the two types of ZnO
induced a more persistent response which did not resolve within
24 h, suggesting that the airway response of ZnO includes another
mechanism. One possible explanation is that the more persistent
depression may be driven by the toxic effects of ZnO. Exposure to
ZnO increased the level of proteins in the lungs due to
extravasation of blood protein. Albumin, the most abundant
protein in the blood, is a well-known and potent inhibitor of lung
surfactants (LS) (Taeusch et al., 2005). The function of LS is to
reduce the surface tension at the air–liquid interface in the
bronchioles and alveoli thereby making breathing more effortless.
The high levels of protein in BAL fluid from ZnO-exposed mice
are therefore likely to contribute to the pronounced and long-
lasting depression of the tidal volume through LS inactivation by
albumin. LS inhibition has shown to lead to partial alveolar
collapse (Taeusch et al., 2005) which consequently reduces the
tidal volume as observed in the present study. The toxicity of ZnO
in the lungs has previously been proposed to be mediated by
Zn2+ ions (Cho et al., 2011). However, the dissolution of ZnO
mainly takes place in the cytosol of macrophages and the rapid
onset of pulmonary effects (560 min of exposure) suggest a direct
effect of the ZnO particles per se. Furthermore, particles may
directly interact with the LS film, which may impair the LS
function making breathing labored. It could be speculated that
inhaling low-soluble particles may compromise LS function due
to adsorption of LS components such as phospholipids or LS-
associated proteins as previously shown for nanosized TiO2
particles (Schleh & Hohlfeld, 2009).
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